Nluc Reporter Cell Line - C6

The C6 cell line is a widely used rat glioma cell line derived from a tumor induced by N-nitrosomethylurea in Wistar rats. C6 cells exhibit typical characteristics of malignant gliomas, such as rapid proliferation, invasiveness, and the ability to form tumors in animal models. They express various markers associated with astrocytes and oligodendrocytes, allowing researchers to study glial cell-specific pathways, cell signaling, and responses to therapeutic interventions. The robustness and adaptability of C6 cells in in vitro culture make them a preferred model for both in vitro and in vivo studies, greatly contributing to the understanding of tumor biology, drug resistance, and potential therapeutic strategies for glioblastoma and other central nervous system malignancies.

The Nluc reporter cell line-C6 is a genetically engineered version of the C6 cell line that expresses NanoLuc luciferase (Nluc), a novel bioluminescent reporter enzyme known for its superior brightness, small size, and stability. This modification makes the C6 cell line a powerful tool for real-time monitoring of cellular processes and high-throughput screening applications. In drug discovery, the Nluc reporter cell line-C6 allows for sensitive quantification of compound efficacy and toxicity by measuring luminescence signals correlated with cell viability, proliferation, or specific pathway activation. Researchers utilize this cell line to track tumor growth dynamics in xenograft models, assess metastatic potential, and evaluate the effects of immunotherapies or targeted therapies on glioma cells. Furthermore, it facilitates the study of gene expression regulation, protein-protein interactions, and intracellular signaling cascades through luciferase-based assays.